Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) have been assigned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average […]
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Get Free Report) has earned a consensus rating of “Hold” from the eight analysts that are currently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month target price among […]
Intercept Pharmaceuticals (NASDAQ:ICPT) Stock Rating Lowered by B Riley theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT – Free Report) – Stock analysts at Leerink Partnrs increased their Q4 2023 earnings per share (EPS) estimates for shares of Intercept Pharmaceuticals in a research report issued to clients and investors on Thursday, August 24th. Leerink Partnrs analyst T. Smith now forecasts that the biopharmaceutical company will earn $0.12 per […]
StockNews.com assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently commented on ICPT. Canaccord Genuity Group lifted their price objective on Intercept Pharmaceuticals from $19.00 to […]